Additionally, for solution-phase examinations we only observed FcγR activation by pCRP when using relatively high concentrations of pCRP (>100 μg/ml), which are only present in patients under certain conditions, e.g., severe inflammation or sepsis. The gene discussed is FCGR2A; the disease is Sepsis.